Affy Parenterals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-11-2024
- Paid Up Capital ₹ 1.00 M
as on 15-11-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.85 Cr
as on 15-11-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets %
(FY 2023)
About Affy Parenterals
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.85 Cr.
Aditya Billa, Arvind Billa, and Sangeeta Billa serve as directors at the Company.
- CIN/LLPIN
U25199DL2019PTC359454
- Company No.
359454
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Affy Parenterals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Billa  | Director | 27-Dec-2019 | Current |
| Arvind Billa | Director | 27-Dec-2019 | Current |
| Sangeeta Billa | Director | 27-Dec-2019 | Current |
Financial Performance of Affy Parenterals.
Affy Parenterals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Affy Parenterals?
Unlock access to Affy Parenterals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Affy Pharma Private LimitedActive 34 years 4 monthsAditya Billa, Arvind Billa and 1 more are mutual person
Affy Hygiene Private LimitedActive 4 years 11 monthsAditya Billa, Arvind Billa and 1 more are mutual person
- Affy Synthetics Private LimitedActive 4 years 11 months
Aditya Billa, Arvind Billa and 1 more are mutual person
- Affy Polymers Private LimitedActive 5 years 11 days
Aditya Billa, Arvind Billa and 1 more are mutual person
- Affy Hospitality Private LimitedActive 4 years 11 months
Aditya Billa and Arvind Billa are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Jun 2023 | ₹5.85 Cr | Open |
How Many Employees Work at Affy Parenterals?
Unlock and access historical data on people associated with Affy Parenterals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Affy Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Affy Parenterals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
